KRT88P and hepatitis B virus infection: For anti-HBc+ donor liver transplantation, the rate of reinfection in HBsAg−/anti-HBc+/anti-HBs+ recipients is reportedly significantly lower than that of HBsAg−/anti-HBc−/anti-HBs+ recipients or HBsAg−/anti-HBc−/anti-HBs− recipients (1.4 versus 9.4 percent versus 13 percent), which may be associated with immune memory preservation after anti-HBs and previous hepatitis B infection [102].